H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Neuroscience D-index 60 Citations 12,827 178 World Ranking 1381 National Ranking 142
Medicine D-index 76 Citations 20,653 252 World Ranking 11392 National Ranking 1021

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Parkinson's disease
  • Disease

His primary scientific interests are in Parkinson's disease, Deep brain stimulation, Neuroscience, Dementia and Disease. His Parkinson's disease study deals with the bigger picture of Internal medicine. His Deep brain stimulation research focuses on Subthalamic nucleus in particular.

His Neuroscience study integrates concerns from other disciplines, such as Neurodegeneration and Insulin resistance. His Dementia research incorporates themes from Risk factor, Cohort and Bioinformatics. His studies in Disease integrate themes in fields like Genetics and Pathological.

His most cited work include:

  • Evolution of cognitive dysfunction in an incident Parkinson's disease cohort (676 citations)
  • Adaptive Deep Brain Stimulation in Advanced Parkinson Disease (662 citations)
  • The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort (626 citations)

What are the main themes of his work throughout his whole career to date?

Thomas Foltynie focuses on Parkinson's disease, Deep brain stimulation, Neuroscience, Subthalamic nucleus and Disease. Thomas Foltynie combines subjects such as Dementia and Physical medicine and rehabilitation with his study of Parkinson's disease. In his study, which falls under the umbrella issue of Deep brain stimulation, Tics is strongly linked to Tourette syndrome.

The study of Neuroscience is intertwined with the study of Beta in a number of ways. His research investigates the connection between Disease and topics such as Cohort that intersect with problems in Pediatrics. His biological study spans a wide range of topics, including Endocrinology, Oncology and Pathology.

He most often published in these fields:

  • Parkinson's disease (57.86%)
  • Deep brain stimulation (40.32%)
  • Neuroscience (34.40%)

What were the highlights of his more recent work (between 2018-2021)?

  • Parkinson's disease (57.86%)
  • Deep brain stimulation (40.32%)
  • Disease (20.50%)

In recent papers he was focusing on the following fields of study:

Parkinson's disease, Deep brain stimulation, Disease, Neuroscience and Physical medicine and rehabilitation are his primary areas of study. The subject of his Parkinson's disease research is within the realm of Internal medicine. His work deals with themes such as Neurology, Oncology and Gene mutation, which intersect with Internal medicine.

His research in Deep brain stimulation intersects with topics in Stimulation, Dyskinesia and Tourette syndrome. The various areas that he examines in his Disease study include Incidence, Bioinformatics, Diabetes mellitus, Intensive care medicine and Pharmacotherapy. His Physical medicine and rehabilitation research is multidisciplinary, incorporating perspectives in Anterior cingulate cortex, Ventral striatum, Hypokinesia and Motor dysfunction.

Between 2018 and 2021, his most popular works were:

  • Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies (353 citations)
  • Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients with Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial (69 citations)
  • Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial. (62 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Parkinson's disease

Thomas Foltynie mostly deals with Parkinson's disease, Disease, Deep brain stimulation, Internal medicine and Subthalamic nucleus. His work carried out in the field of Parkinson's disease brings together such families of science as Genome-wide association study and Bioinformatics. His Disease study combines topics from a wide range of disciplines, such as Incidence, Diabetes mellitus, Type 2 diabetes, Intensive care medicine and Genetic association.

His Deep brain stimulation research is multidisciplinary, incorporating elements of Orbitofrontal cortex, Physical medicine and rehabilitation, Resting state fMRI, Neuroscience and Tourette syndrome. His Internal medicine research integrates issues from Oncology and Gene mutation. Thomas Foltynie interconnects Phonation, Audiology, Functional magnetic resonance imaging, Verbal fluency test and Direct pathway of movement in the investigation of issues within Subthalamic nucleus.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Evolution of cognitive dysfunction in an incident Parkinson's disease cohort

C. H. Williams-Gray;T. Foltynie;C. E. G. Brayne;T. W. Robbins.
Brain (2007)

974 Citations

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

Caroline H. Williams-Gray;Jonathan R. Evans;An Goris;An Goris;Thomas Foltynie.
Brain (2009)

868 Citations

The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study

Thomas Foltynie;Carol E. G. Brayne;Trevor W. Robbins;Roger A. Barker.
Brain (2004)

811 Citations

Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

D. Aarsland;K. Bronnick;C. Williams-Gray;D. Weintraub.
Neurology (2010)

807 Citations

Adaptive Deep Brain Stimulation in Advanced Parkinson Disease

Simon Little;Alex Pogosyan;Spencer Neal;Baltazar Zavala.
Annals of Neurology (2013)

769 Citations

Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach

S J G Lewis;T Foltynie;A D Blackwell;T W Robbins.
Journal of Neurology, Neurosurgery, and Psychiatry (2005)

575 Citations

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort

Caroline H Williams-Gray;Sarah L Mason;Jonathan R Evans;Thomas Foltynie.
Journal of Neurology, Neurosurgery, and Psychiatry (2013)

454 Citations

Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review: Clinical article

Ludvic Zrinzo;Thomas Foltynie;Patricia Limousin;Marwan I. Hariz;Marwan I. Hariz.
Journal of Neurosurgery (2012)

359 Citations

Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

Mike A Nalls;Cornelis Blauwendraat;Costanza L Vallerga;Karl Heilbron.
Lancet Neurology (2019)

353 Citations

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Dilan Athauda;Kate Maclagan;Simon S Skene;Martha Bajwa-Joseph.
The Lancet (2017)

342 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Thomas Foltynie

Peter Brown

Peter Brown

University of Oxford

Publications: 137

Roger A. Barker

Roger A. Barker

University of Cambridge

Publications: 134

Dag Aarsland

Dag Aarsland

King's College London

Publications: 115

Andrew B. Singleton

Andrew B. Singleton

National Institutes of Health

Publications: 109

Andrea A. Kühn

Andrea A. Kühn

Charité - University Medicine Berlin

Publications: 103

Andres M. Lozano

Andres M. Lozano

University Health Network

Publications: 96

Daniel Weintraub

Daniel Weintraub

University of Pennsylvania

Publications: 92

Thomas Gasser

Thomas Gasser

University of Tübingen

Publications: 90

Daniela Berg

Daniela Berg

Kiel University

Publications: 89

Michael S. Okun

Michael S. Okun

University of Florida

Publications: 87

Alfonso Fasano

Alfonso Fasano

Allen Institute for Brain Science

Publications: 83

David J. Burn

David J. Burn

Newcastle University

Publications: 80

John Hardy

John Hardy

University College London

Publications: 77

Mike A. Nalls

Mike A. Nalls

National Institutes of Health

Publications: 63

Mark R. Cookson

Mark R. Cookson

National Institutes of Health

Publications: 62

Andreas Horn

Andreas Horn

Charité - University Medicine Berlin

Publications: 59

Something went wrong. Please try again later.